Loss of p27Kip1 accelerates DNA replication after partial hepatectomy in mice

Journal of Surgical Research

Volumn 111, Issue 2, 2003, Pages 196-202

  Hayashi, Eiji ^a,b,c   Yasui, Akihiro ^b   Oda, Koji ^c   Nagino, Masato ^c   Nimura, Yuji ^c   Nakanishi, Makoto ^d   Motoyama, Noboru ^a   Ikeda, Kyoji ^a   Matsuura, Akira ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Cdk inhibitors; DNA synthesis; Liver regeneration; p27Kip1; Partial hepatectomy

Indexed keywords

PROTEIN CDK; PROTEIN INHIBITOR; PROTEIN P27; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA REPLICATION; KNOCKOUT MOUSE; LIVER REGENERATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FAMILY; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

EID: 0037678907     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00052-0     Document Type: Article

References (35)

1. Nimura Y., Hayakawa N., Kamiya J., Kondo S., Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic bilus. World J. Surg. 14:1990;535.
2. Nimura Y., Hayakawa N., Kamiya J., Maeda S., Kondo S., Yasui A., Shionoya S. Combined portal vein and liver resection for carcinoma of the biliary tract. Br. J. Surg. 78:1991;727.
3. Nimura Y., Hayakawa N., Kamiya J., Maeda S., Kondo S., Yasui A., Shionoya S. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology. 38:1991;170.
4. Nagino M., Nimura Y., Hayakawa N., Kamiya J., Kondo S., Sasaki R., Hamajima N. Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J. Surg. 17:1993;250.
5. Nagino M., Ando M., Kamiya J., Uesaka K., Sano T., Nimura Y. Liver regeneration after major hepatectomy for biliary cancer. Br. J. Surg. 88:2001;1084.
6. Higgins G.M., Anderson R.M. Experimental pathology of the liver. Restoration of the liver of the rat following partial surgical removal. Arch. Pathol. 12:1931;186.
7. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149.
8. Takahashi H., Menjo M., Kaneko Y., Ikeda K., Matsushime H., Nakanishi M. Cdk4 activation is dependent on the subunit rearrangement in the complexes. Biochem. Biophys. Res. Commun. 267:2000;388.
9. Menjo M., Ikeda K., Nakanishi M. Regulation of G1 cyclin-dependent kinases in liver regeneration. J. Gastroenterol. Hepatol. 13:(Suppl):1998;100.
10. Norbury C., Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem. 61:1992;441.
11. Nurse P. Ordering S phase and M phase in the cell cycle. Cell. 79:1994;547.
12. Sherr C.J. G1 phase progression cycling on cue . Cell. 79:1994;551.
13. Hunter T., Pines J. Cyclins and cancer. II Cyclin D and CDK inhibitors come of age . Cell. 79:1994;573.
14. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59.
15. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:1994;67.
16. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707.
17. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721.
18. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., Kaushansky K., Roberts J.M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:1996;733.
19. Karnezis A.N., Dorokhov M., Grompe M. and Zhu. L. Loss of p27(Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J. Clin. Invest. 108:2001;383.
20. Albrecht J.H., Poon R.Y., Ahonen C.L., Rieland B.M., Deng C., Crary G.S. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Oncogene. 16:1998;2141.
21. Jaumot M., Estanyol J.M., Serratosa J., Agell N., Bachs O. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Hepatology. 29:1999;385.
22. Pujol M.J., Jaime M., Serratosa J., Jaumot M., Agell N., Bachs O. Differential association of p21Cip1 and p27Kip1 with cyclin E-CDK2 during rat liver regeneration. J. Hepatol. 33:2000;266.
23. Ledda-Columbano G.M., Pibiri M., Loi R., Perra A., Shinozuka H., Columbano A. Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3, 5-Dichloropyridyloxy)] benzene. Am. J. Pathol. 156:2000;91.
24. Rudolph K.L., Chang S., Millard M., Schreiber-Agus N., DePinho R.A. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science. 287:2000;1253.
25. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science. 276:1997;60.
26. Diehl A.M., Rai R.M. Liver regeneration 3 Regulation of signal transduction during liver regeneration . FASEB J. 10:1996;215.
27. 3H. Cancer Res. 22:1962;842.
28. Gupta S. Hepatic polyploidy and liver growth control. Semin. Cancer Biol. 10:2000;161.
29. Sigal S.H., Rajvanshi P., Gorla G.R., Sokhi R.P., Saxena R., Gebhard D.R., Reid L.M., Gupta S. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am. J. Physiol. 276:1999;G1260.
30. Wu H., Wade M., Krall L., Grisham J., Xiong Y., Van Dyke T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes Dev. 10:1996;245.
31. Sanderson N., Factor V., Nagy P., Kopp J., Kondaiah P., Wakefield L., Roberts A.B., Sporn M.B., Thorgeirsson S.S. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2572.
32. Jirtle R.L., Carr B.I., Scott C.D. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration. J. Biol. Chem. 266:1991;22444.
33. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9.
34. Chen T.C., Ng K.F., Lien J.M., Jeng L.B., Chen M.F., Hsieh L.L. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma. Cancer Lett. 153:2000;169.
35. Fero M.L., Randel E., Gurley K.E., Roberts J.M., Kemp C.J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 396:1998;177.